4.8 Article

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

Related references

Note: Only part of the references are listed.
Article Hematology

Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?

Derek L. Stirewalt et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Review Genetics & Heredity

Stromal-cell regulation of natural killer cell differentiation

Claude Roth et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Article Immunology

Epithelial overexpression of interleukin-32α in inflammatory bowel disease

M. Shioya et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)

Article Rheumatology

IL-32, a novel cytokine with a possible role in disease

C. A. Dinarello et al.

ANNALS OF THE RHEUMATIC DISEASES (2006)

Article Multidisciplinary Sciences

IL-32, a proinflammatory cytokine in rheumatoid arthritis

LAB Joosten et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Immunology

Involvement of IL-32 in activation-induced cell death in T cells

C Goda et al.

INTERNATIONAL IMMUNOLOGY (2006)

Article Multidisciplinary Sciences

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism

MG Netea et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)